Andreas Pahl
Chief Executive Officer bij HEIDELBERG PHARMA AG
Profiel
Dr. Andreas Pahl is a Managing Director at Heidelberg Pharma Research GmbH and a Chief Executive Officer at Heidelberg Pharma AG.
Dr. Pahl was previously employed as a Chief Scientific Officer by Heidelberg Pharma AG /Old/, a Member-Supervisory Board by Emergence Therapeutics AG, a Professor-Pharmacology & Toxicology by Friedrich-Alexander University of Erlangen-Nuremberg, a Head-Late Pharmacology by Nycomed GmbH, a Head-Late Pharmacology by Takeda Pharmaceutical Co., Ltd., and a Professor by Technical University of Berlin.
He received his undergraduate degree from Humboldt-Universität zu Berlin.
Actieve functies van Andreas Pahl
| Bedrijven | Functie | Begin |
|---|---|---|
| HEIDELBERG PHARMA AG | Chief Executive Officer | 01-02-2024 |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Chief Executive Officer | 01-02-2024 |
Eerdere bekende functies van Andreas Pahl
| Bedrijven | Functie | Einde |
|---|---|---|
| Nycomed GmbH | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Director/Board Member | - |
| Friedrich-Alexander University of Erlangen-Nuremberg | Corporate Officer/Principal | - |
| Technical University of Berlin | Corporate Officer/Principal | - |
Opleiding van Andreas Pahl
| Humboldt-Universität zu Berlin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| HEIDELBERG PHARMA AG | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Nycomed GmbH | |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Health Technology |
Heidelberg Pharma AG /Old/
 Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Heidelberg Pharma AG provides drug development services. The firm also provides services for the pre-clinical development of new chemical or biological entities, which includes drug metabolism- and pharmacokinetic (DMPK) studies and pharmacology services in the field of cancer, inflammatory and autoimmune diseases. The company was founded in 1999 and is headquartered in Ladenburg, Germany. | Commercial Services |
